NEW YORK (GenomeWeb) – Oxford Genetics said today it has received $500,000 in funding from Innovate UK to support the development of its mammalian display antibody technology.

According to Oxford Genetics, its technology allows for candidate antibodies to be screened against human proteins in their naturally occurring state, as opposed to traditional methods that rely on yeast or animal expression systems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Sponsored by

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.